Update History
Condition: Alpha-1 Antitrypsin Deficiency
Gene/Gene Panel: SERPINA1
Context: Adult
2022/02/09
Released
1.2.2
COPD
(GroupA)
Smoking cessation
(GroupA)
10CA
Emphysema
(GroupA)
A1AT augmentation therapy
(GroupA)
7CD
Liver disease
(GroupA)
Limit alcohol consumption
(GroupA)
9CC
Internal system migration associated with MONDO name addition.
2022/02/09
Released
(Under revision)
1.2.1
COPD
(GroupA)
Smoking cessation
(GroupA)
10CA
Emphysema
(GroupA)
A1AT augmentation therapy
(GroupA)
7CD
Liver disease
(GroupA)
Limit alcohol consumption
(GroupA)
9CC
MONDO IDs added
2020/05/02
Released
1.2.1
COPD
(GroupA)
Smoking cessation
(GroupA)
10CA
Emphysema
(GroupA)
A1AT augmentation therapy
(GroupA)
7CD
Liver disease
(GroupA)
Limit alcohol consumption
(GroupA)
9CC
MONDO IDs added
2020/05/02
Released
(Under revision)
1.2.0
COPD
(GroupA)
Smoking cessation
(GroupA)
10CA
Emphysema
(GroupA)
A1AT augmentation therapy
(GroupA)
7CD
Liver disease
(GroupA)
Limit alcohol consumption
(GroupA)
9CC
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/10/03
Released
1.2.0
COPD
(GroupA)
Smoking cessation
(GroupA)
10CA
Emphysema
(GroupA)
A1AT augmentation therapy
(GroupA)
7CD
Liver disease
(GroupA)
Limit alcohol consumption
(GroupA)
9CC
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/04/04
Released
1.1.0
COPD
Smoking cessation
10CA
Emphysema
A1AT augmentation therapy
7CD
Liver disease
Limit alcohol consumption
9CC
Internal system migration related to merging adult and pediatric contexts.
2018/11/01
Released
1.0.3
COPD
Smoking cessation
10CA
Emphysema
A1AT augmentation therapy
7CD
Liver disease
Limit alcohol consumption
9CC
Internal system migration related to score text replacement from E to N
2018/05/02
Released
1.0.2
COPD
Smoking cessation
10CA
Emphysema
A1AT augmentation therapy
7CD
Liver disease
Limit alcohol consumption
9CC
2018/05/02
Released
(Under revision)
1.0.1
COPD
Smoking cessation
10CA
Emphysema
A1AT augmentation therapy
7CD
Identify those at risk to and institute interventions appropriate to severity
Serum A1AT measurement
11CC
Liver disease
Limit alcohol consumption
9CC
2018/01/11
Released
1.0.1
COPD
Smoking cessation
10CA
Emphysema
A1AT augmentation therapy
7CD
Identify those at risk to and institute interventions appropriate to severity
Serum A1AT measurement
11CC
Liver disease
Limit alcohol consumption
9CC
2017/10/23
Released
1.0.0
COPD
Smoking cessation
10CA
Emphysema
A1AT augmentation therapy
7CD
Identify those at risk to and institute interventions appropriate to severity
Serum A1AT measurement
11CC
Liver disease
Limit alcohol consumption
9CC